Account
Carat India bags integrated media duty of Pfizer Magnum
MUMBAI Following a multi-agency pitch, Carat India has won the media mandate of Pfizer Magnum business division. The key parameters that helped Carat win the business are an integrated communication approach, along with innovative ideas that will enhance the brand image.
Carat starts this wonderful relationship through a Pan India launch of Gelusil sachet campaign. This campaign brings to the fore a humorous element depicted by Javed Jafri as the brand ambassador. This sachet campaign will see all forms of media being explored – traditional media, digital, out-of-home, and an interesting storytelling format in the form of co-creating content to engage the audience.
Commenting on the win, Carat India MD Kartik Iyer said, “We are delighted that Pfizer found value in the unique approaches we presented on the tasks we were briefed on. It’s an absolute honour to have been selected as their partner and by creating integrated engaging solutions we look forward to partnering the team in taking the various brands of Pfizer from strength to strength in India.”
Carat India SVP- west Himanka Das added, “We are delighted to handle a portfolio of heritage brands such as Gelusil and Becosules that will push us to take the brand conversations to the next level through innovative path breaking approaches both traditionally and digitally. Our vision is to redefine media strategy to deliver gold-standard approach when it comes to the clients’ businesses through media and communications. This is a tremendous opportunity for us to leverage our strengths in consumer insights through our proprietary tool CCS to deliver cutting edge integrated media strategy in a digitally convergent world.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
